Live Breaking News & Updates on Group Technology Division

Stay updated with breaking news from Group technology division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Grants Donisi De Novo Clearance for Innovative Contact-Free Multiparameter Health Sensing Solution


Share this article
Share this article
TEL AVIV, Israel, May 5, 2021 /PRNewswire/  The U.S. Food and Drug Administration (FDA) has granted Donisi s revolutionary contact-free multiparameter measurement system de novo clearance, making Donisi the first to bring this innovative technology to the medical market.
In addition to the de novo clearance, the ingenuity of Donisi s groundbreaking system was recently recognized via the publication of their clinical validation study in the Journal of Medical Engineering & Technology and winning first place in the MEDinISRAEL OpenMED Innovation Competition.
Contact-Free Health Measurement and Decision Support. Donisi: Changing Lives Without Changing Lifestyles
I m really proud of our team; we developed a medical device that can change the lives of millions of people. Our novel technology is now recognized and cleared by FDA which is a great accomplishment, said Donisi CEO, Yair Brosh. ....

Sagi Polani , Eyal Agmoni , Yair Brosh , Donisi Health , Journal Of Medical Engineering Technology , Tel Aviv Sourasky Medical Center , Drug Administration , Cardiovascular Research Center , Group Technology Division , Medical Engineering , Tel Aviv Sourasky Medical , Donisi Chief Medical Officer , Chartered Group Technology Division , Managing General Partner , Japan Israel High Tech Ventures , Use Biometrics , Continuse Biometrics , Ba Donisi Health , இருதய ஆராய்ச்சி மையம் , மருத்துவ பொறியியல் , நிர்வகித்தல் ஜநரல் கூட்டாளர் , ஜப்பான் இஸ்ரேல் உயர் தொழில்நுட்பம் முயற்சிகள் , பயன்பாடு பயோமெட்ரிக்ஸ் ,